Entera Bio Ltd. Ordinary Shares

Go to Entera Bio Ltd. Ordinary Shares Website

$2.03

-0.05 (-2.40%)
Live
Previous Close

$2.08

Day Range

$2.02 - $2.135

Previous Day Range

$1.99 - $2.1394

Market Cap

$88.6 million USD

Day Vol.

58344

Previous Day Vol.

190742

Currency

USD

Primary Exchange

Nasdaq

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where ...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

OPKO Health, Inc. and Entera Bio Ltd. announced that OPKO's ModeX Therapeutics division has formed a Scientific Advisory Board with leaders in immunology and oncology drug development. Additionally, OPKO and Entera's first-in-class dual GLP-1/Glucagon tablet candidate for obesity and metabolic disorders has been selected for presentation at the ENDO 2025 Annual Meeting.

Related tickers: OPK, ENTX.

Read Full Article

OPKO Health and Entera Bio have entered into a collaboration agreement to advance an oral GLP-1/Glucagon dual agonist tablet into clinical trials for the treatment of obesity and metabolic disorders.

Related tickers: OPK, ENTX.

Read Full Article
Trending Tickers

Please sign in to view